Liquidity in Drug Discovery – Bharath Ramsundar – Decentralized Protocol and Deep Drug Discovery Researcher
One of the most fundamental problems in drug discovery is that potential drugs don’t have market value until they’ve passed human trials. Unfortunately for prospective drug hunters, running human trials of proposed medicine costs tremendous amounts of money. As a result, only a few players are capable of creating salable assets in drug discovery. The market is essentially discrete; large amounts of money are divided up among perhaps a dozen new approved drugs per year. This situation chokes innovation, since available capital has to be funneled into relatively conservative bets.
Liquidity in Drug Discovery One of the most fundamental problems in drug discovery is that potential drugs don’t have market value until they’ve passed human trials. Unfortunately for prospective drug hunters, running human trials of proposed medicine costs tremendous amounts of money. As a result, only a few players are capable of creating salable assets in drug discovery. The market is essentially discrete; large amounts of money are divided up among perhaps a dozen new approved drugs per year. This situation chokes innovation, since available capital has to be funneled into relatively conse
Explore this link on the map →saved by
related reading
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- How unfair is the coin?ankitg.me
- Why is progress in biology so slow?sam-rodriques.com
- How Life Sciences Actually Work: Findings of a Year-Long Investigation - Alexey Guzeyguzey.com
- Curious cases of financial engineering in biotechowlposting.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communicationsnature.com
- A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communicationsnature.com
- Some questions about biotech that I find interesting | Alex’s blogatelfo.github.io
- Market Failures in Sciencemilan.cvitkovic.net
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- The rise and fall of the industrial R&D lab - Works in Progress Magazineworksinprogress.co